Glaucoma Therapeutics Market by Product Type, Distribution Channel, End User 2024-2032

The global glaucoma therapeutics market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.

More Info:- https://www.imarcgroup.com/glaucoma-therapeutics-market

1. Global Glaucoma Therapeutics Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

2. About IMARC Group IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. Across the six major continents and 100+ countries, we work alongside our business partners as one team with a common ambition to achieve unparalleled results, gain a competitive edge, and transform industries. IMARC Group excels in understanding its clients’ business priorities and delivering tailored solutions that drive meaningful outcomes. Our client base spans over 3,000 organizations in the private, public, and social sectors, ranging from high-growth startups to Fortune 500 companies. We provide a comprehensive suite of market entry and expansion services. Our offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. These services are designed to assist companies in evaluating market opportunities, setting up new entities, navigating regulatory landscapes, boosting brand visibility, analyzing competitors, and optimizing procurement strategies.

3. Report Highlight and Description According to the latest report by IMARC Group, titled  "Glaucoma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,"  the  global glaucoma therapeutics market size reached US$ 7.9 Billion in 2023. Glaucoma is an ocular disorder that damages the optic nerve of the patient. The structural changes in the optic nerves are usually caused by the abnormally high intraocular pressure (IOP) due to the extra build-up of fluid in the front part of the eyes. This condition can often lead to vision loss and permanent blindness in progressive cases. Numerous medications and therapies are prescribed to patients with glaucoma in order to avoid complete vision loss. Eye drops that belong to the class of beta-blockers, alpha agonists, prostaglandins and cholinergic are usually prescribed to reduce the production of fluid in the eyes. These drops can then be followed by conventional or laser surgeries for effective results. In several cases, a combination of both approaches is utilized for the treatment of glaucoma. Request for a PDF sample of this report: https://www.imarcgroup.com/glaucoma-therapeutics-market/requestsample

4. Report Description Global Glaucoma Therapeutics Market Trends : The market is primarily driven by the increasing occurrence of glaucoma on the global level. This can be attributed to the rising number of patients who have diabetes due to their shifting lifestyle patterns and a lack of physical activities. This, along with the increasing geriatric population that is more susceptible to chronic ocular disorders, is providing a thrust to the market growth. Along with this, there has been a growing preference for the adoption of laser glaucoma surgeries among the patients as well as the healthcare professionals on account of the successful outcomes of this procedure. Multiple professionals are also prescribing combination therapies for the treatment of glaucoma that involves the use of polymer-based contact lenses, drug-eluting punctal plugs, implantable extended-release devices, microneedle-injection devices and micro-dosing technologies. Coupled with the increasing number of awareness programs conducted by multiple organizations to spread awareness regarding the availability of effective glaucoma therapeutics, this is creating a positive outlook for the market. Some of the other factors contributing to the market growth include the continual research and development (R&D) activities to introduce innovative therapeutics and the improving healthcare infrastructure across the globe, especially in developing economies. Looking forward, the market is expected to grow at a CAGR of 5.6% during 2024-2032. View Report TOC, Figures and Tables : https://www.imarcgroup.com/glaucoma-therapeutics-market

5. Report Segmentation Breakup by Drug Class: Prostaglandin Analogs Beta Blockers Alpha Adrenergic Agonists Carbonic Anhydrase Inhibitors Combination Drugs Others Breakup by Indication: Open Angle Glaucoma Angle Closure Glaucoma Others Breakup by End User: Hospitals

6. Report Segmentation Ophthalmic Clinics Ambulatory Surgery Centers Others Breakup by Region: North America Asia-Pacific Europe Latin America Middle East and Africa

7. Competitive Landscape with Key Players Aerie Pharmaceuticals Inc. Allergan Plc Bausch & Lomb Incorporated (Bausch Health Companies Inc.) Inotek Pharmaceuticals Corp. Merck & Co. Inc. Novartis AG Pfizer Inc. Santen Pharmaceutical Co. Ltd. SIFI S.p.A Teva Pharmaceutical Industries Ltd

8. Key Questions Answered in the Report

9. Table of Contents 1    Preface 2    Scope and Methodology     2.1    Objectives of the Study     2.2    Stakeholders     2.3    Data Sources         2.3.1    Primary Sources         2.3.2    Secondary Sources     2.4    Market Estimation         2.4.1    Bottom-Up Approach         2.4.2    Top-Down Approach     2.5    Forecasting Methodology 3    Executive Summary 4    Introduction     4.1    Overview     4.2    Key Industry Trends 5    Global Glaucoma Therapeutics Market     5.1    Market Overview     5.2    Market Performance     5.3    Impact of COVID-19   5.4    Market Forecast 6     Market Breakup by Drug Class 6.1 Prostaglandin Analogs 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Beta Blockers 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Alpha Adrenergic Agonists 6.3.1 Market Trends 6.3.2 Market Forecast        

10. Table of Contents 6.4 Carbonic Anhydrase Inhibitors 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Combination Drugs 6.5.1 Market Trends 6.5.2 Market Forecast 6.6 Others 6.6.1 Market Trends 6.6.2 Market Forecast 7 Market Breakup by Indication 7.1 Open Angle Glaucoma 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Angle Closure Glaucoma 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Others 7.3.1 Market Trends 7.3.2 Market Forecast 8 Market Breakup by End User 8.1 Hospitals 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Ophthalmic Clinics 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Ambulatory Surgery Centers 8.3.1 Market Trends 8.3.2 Market Forecast For more information, visit : https://www.imarcgroup.com/glaucoma-therapeutics-market/toc

11. Partial List of Clients

12. Partial List of Clients

13. Disclaimer © 2024 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

14. Contact Us Visit us at : https://www.imarcgroup.com [phone] [email protected] Stay With Us: